Chemed (CHE) Stock Price
Chemed Price
Revenue has compounded at 4.9% per year over the past 19 years to 2.53 B USD. Earnings per share have grown at 12.7% per year over the last 19 years. Chemed's net margin stands at 10.5%, down from 12.6% several years earlier. Chemed currently offers a dividend yield of about 0.43%. The payout ratio is around 12% of earnings. The dividend has grown at 12.4% per year over the past 19 years. Analysts set a median price target of 554.00 USD, implying 8.8% above the current price. Of 8 analysts, 4 rate the stock a buy — an overall Buy consensus.
Chemed stock price
Chemed business model & stock analysis
Frequently asked questions about Chemed
The business model of Chemed Corp focuses on providing end-of-life care services through its subsidiaries, VITAS Healthcare and Roto-Rooter. Chemed Corp operates in two segments: VITAS, which offers hospice services to patients with life-limiting illnesses, and Roto-Rooter, a leading provider of plumbing and drain cleaning services. VITAS prioritizes compassionate care, aiming to enhance quality of life for patients and support their families. Roto-Rooter, on the other hand, provides essential plumbing solutions, specializing in emergency repairs, maintenance, and installation services. Chemed Corp's business model emphasizes delivering high-quality and specialized services in the healthcare and plumbing sectors, positioning itself as a reliable and trusted provider.
Chemed Corp is primarily active in the healthcare and service industries.
The main competitors of Chemed Corp in the market include companies such as Amedisys Inc, Brookdale Senior Living Inc, and Encompass Health Corporation.
Chemed Corp is a renowned company with a rich history and compelling background. Established in 1970, Chemed Corp began as a provider of plumbing and drain cleaning services through its Roto-Rooter subsidiary. Over the years, it expanded its operations and diversified into healthcare services. Currently, Chemed Corp is a leading provider of hospice and palliative care services through its subsidiary, VITAS Healthcare. The corporation's commitment to exceptional patient care has earned it a stellar reputation in the healthcare industry. Chemed Corp continues to grow and flourish, upholding its core values and consistently delivering outstanding services to those in need.
Chemed Corp has achieved several significant milestones throughout its history. The company experienced strong growth and expanded its services, becoming a leader in the healthcare industry. Chemed Corp's subsidiary, VITAS Healthcare, has reached noteworthy achievements, including the provision of compassionate end-of-life care to thousands of patients and their families. Additionally, Chemed Corp successfully acquired and integrated various companies, enhancing its business portfolio and market presence. The company's commitment to innovation, quality care, and strategic acquisitions has contributed to its continued success and recognition within the industry.
Chemed Corp is primarily present in the United States.
Chemed Corp is a company known for exemplifying values of integrity, excellence, and innovation. With a strong corporate philosophy, Chemed prioritizes a customer-centric approach, constantly striving to meet and exceed their expectations. Their commitment to ethical practices and the highest standards in healthcare services distinguish them in the industry. Chemed also emphasizes the importance of fostering a positive work environment, valuing their employees and promoting professional growth. By consistently delivering exceptional results, Chemed reflects a dedication to long-term success and sustainable progress.
Analysts currently set an average price target of 554.00 USD for the Chemed stock (median: 554.00 USD), implying +9.2 % versus the latest price. The consensus is based on 8 analyst ratings.
8 analysts currently rate the Chemed stock: 4 recommend buying, 4 holding and 0 selling. For 2026, analysts expect Chemed to generate revenue of 2.72 B USD and earnings per share of 27.67 USD.
Converted at the current exchange rate, the Chemed share trades at 452.52 EUR (509.08 USD).
The Chemed share (CHE) is listed on 2 stock exchanges, including: NYSE (CHE), Frankfurt (CXM.F).
Chemed Corp is a US-based company operating in the hospice and drain cleaning sectors. It was founded in 1970 and is headquartered in Cincinnati, Ohio. Hospice services: Chemed Corp is the parent company of Vitas Healthcare, one of the largest hospice providers in the US. Vitas Healthcare offers a wide range of services for patients with life-threatening illnesses, including home care, support for family members and caregivers, pain therapy, and emotional support. Vitas Healthcare has a nationwide network of hospice centers and is a preferred hospice provider for Medicare, Medicaid, and private insurance companies. The company has also built partnerships with hospitals and nursing facilities to provide its customers access to top-quality care. Drain cleaning services: Chemed Corp also operates Roto-Rooter, one of the leading drain cleaning and plumbing companies in North America. The company offers a wide range of services, including pipe cleaning, sewer rehabilitation, and inspections of residential and commercial areas. Roto-Rooter is available 24/7 and offers emergency services. The company has also built a network of franchisees offering their services in multiple countries worldwide. Other business areas: In addition, Chemed Corp also operates milk production management consulting through its subsidiary Agri-Best. The company provides consulting services for dairy farms and assists with diets and feeding plans for dairy cows, among other services. Products: Chemed Corp offers a wide range of products for the hospice and drain cleaning sectors. For example, Vitas Healthcare offers medical supply products for customers and their environments, including respiratory aids, medical devices, and infusion pumps. Roto-Rooter offers plumbing products such as drain cleaners and pipes. Summary: Chemed Corp is a company operating in the hospice and drain cleaning sectors. The company offers a wide range of services and operates subsidiaries such as Vitas Healthcare and Roto-Rooter. Chemed Corp is also active in other business areas such as dairy management. The company offers a variety of products relevant to its different business sectors.
The expected revenue of Chemed is 2.72 B USD. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Chemed is 387.15 M USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Chemed is currently 18.40. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Chemed stock.
The price-to-sales ratio (P/S) of Chemed is currently 2.62. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Chemed stock.
The Eulerpool Quality Score for Chemed is 6/10.
The ISIN of Chemed is US16359R1032. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Chemed is A0CBF4. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Chemed is CHE. The ticker symbol is used to trade Chemed shares on the stock exchange.
Chemed stock
Chemed Peer Group
Chemed Ticker
Chemed FIGI
All fundamentals and in-depth analysis of Chemed
Our stock analysis for Chemed stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Chemed. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.